BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.170
-0.030 (-2.50%)
At close: Jul 6, 2026, 4:00 PM EDT
1.172
+0.002 (0.13%)
After-hours: Jul 6, 2026, 7:52 PM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $13.31 million as of July 6, 2026. Its market cap has increased by 21.24% in one year.
Market Cap
13.31M
Enterprise Value
12.78M
1-Year Change
21.24%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $13.31M, a decrease of -54.23%. That is a compound annual growth rate of -7.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 13.31M | 0.32% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 15.25M |
| Passage Bio | 15.01M |
| BioVie | 14.71M |
| Cyclerion Therapeutics | 14.55M |
| Lunai Bioworks | 14.51M |
| Cocrystal Pharma | 14.34M |
| Moleculin Biotech | 14.09M |
| IN8bio | 13.98M |